Nebula Research & Development’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,508	Closed	-$161K	–	1126
2024 Q3	$161K	Buy	+11,508	New	+$161K	0.02%	852
2024 Q2	–	Sell	-12,698	Closed	-$97.9K	–	1052
2024 Q1	$97.9K	Buy	+12,698	New	+$97.9K	0.02%	691